Kanchi Karpooram enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
0.90.91.81.71.3
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
Reference items — trailing FY values
148148151127205
12.312.323.05.222.1
8.48.419.42.419.2
−6.2−6.25.917.535.7
−9.7−9.7−2.48.414.9
−10.0−10.0−2.48.414.9
3.53.58.39.120.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KANCHI₹375.25

Kanchi Karpooram Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASGRAUWEILINDOKEMJYOTIRES
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current
last close
- Cash, Equiv & ST Investments1.31.71.80.90.9
Reference Items — Trailing FY Values
Sales205.4127.1151.5147.8147.8
EBITDA22.15.223.012.312.3
EBIT19.22.419.48.48.4
Operating Cash Flow35.717.55.9-6.2-6.2
Free Cash Flow14.98.4-2.4-9.7-9.7
FCFF (free cash flow to the firm)14.98.4-2.4-10.0-10.0
Capital Expenditure20.89.18.33.53.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.